Molecular diagnoses of century-old childhood tumours reveals cancer causing mutations

24 May 2017, 2:29 p.m.

Archived tumour samples

A collection of 100-year old tumour samples held at Great Ormond Street Hospital (GOSH) has helped pinpoint the genetic mutations that cause some of the rarest childhood cancers.

NIHR Great Ormond Street BRC-theme lead Professor Neil Sebire worked with colleagues at the Wellcome Trust Sanger Institute to sequence DNA from tumour samples that had been preserved in blocks of paraffin wax since the 1920s. The team then cross-referenced the samples with archived patient case books which contain information about the patient’s symptoms, condition and diagnosis. Together this information enabled researchers to identify several cancer causing mutations. In one case of the blood vessel cancer (cellular capillary haemangioma) researchers found a mutation in the ASXL1 gene which had not previously been seen in solid tumours.

This proof of principle study shows that it is possible to obtain genetic information from preserved tissue. It also demonstrates the potential of this approach in understanding the genetic basis of rare childhood cancers where the very low incidences mean contemporary tissue samples are scarce

The research was published in a letter to Lancet Oncology  and featured on Radio 4's Inside Science, The Guardian and Nature News.

Mosaic of over 700 photos wins annual Moment of Discovery Image competition

A beautiful collage made from over 700 photographs taken from across GOSH has been crowned the winner of our 5th annual Research and Innovation image competition ‘A Moment of Discovery’.

New trial to support childhood survivors of brain tumours

Experts at Great Ormond Street Hospital have launched the first trial of its kind to support children’s cognitive development following treatment for a brain tumour.

Professor Waseem Qasim named in list of leading global health leaders

Professor Waseem Qasim, Consultant at GOSH and Professor of Cell and Gene Therapy at University College London has been named in TIME magazine’s 2026 TIME100 Health List of the World’s Most Influential Leaders in Health.

Alyssa Tapley named in list of leading global health leaders

GOSH patient, Alyssa Tapley, 17 from Leicester, has been named in TIME’S 2026 TIME100 Health List of the World’s Most Influential Leaders in Health.